ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 2025

Lupus Education Advancement Project (LEAP): Rheumatology Fellows Serving As Educators Increased Knowledge and Efficiency in Lupus Recognition and Referral By Providers in Primary and Emergency Care

Diane Gross1, Amy Caron2, Irene Blanco3, Alfred Denio4, Sheetal Desai5, Amanda Sammut6 and Zoon Naqvi7, 1S.L.E. Lupus Foundation/Lupus Research Institute, New York, NY, 2Lupus Research Institute, Ny, NY, 3Albert Einstein College of Medicine and Montefiore Medical Center, Bronx, NY, 4Rheumatology, Geisinger Medical Center, Danville, PA, 5Medicine/Rheumatology, Unviersity of California, Irvine, Orange, CA, 6NYC Health and Hospitals/Harlem Hospital Center and Columbia University Medical Center, New York, NY, 7Albert Einstein College of Medicine, Bronx, NY

Meeting: 2016 ACR/ARHP Annual Meeting

Date of first publication: September 28, 2016

Keywords: Education, educational research and health disparities, Lupus, medical, Referrals

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Date: Monday, November 14, 2016

Title: ARHP III: Education and Community Programs

Session Type: ARHP Concurrent Abstract Session

Session Time: 2:30PM-4:00PM

Background/Purpose:  Primary and emergency care providers may have received 45 minutes of lupus education in medical school. Providers may fail in recognizing lupus because symptoms are often vague, delaying referrals and diagnosis for 2-6 years. Delay can lead to accrual of organ damage and death, which is more prevalent in minority populations. Many patients are referred to rheumatology not meeting assessment criteria for lupus, creating barriers to rheumatology care for urgent patients. The goal of LEAP is to increase lupus knowledge and improve lupus assessment and referral procedures among primary and emergency providers within the healthcare system.

Methods : LEAP enlisted rheumatology fellows to serve as educators to deliver a 1 Continuing Medical Education credit seminar. Four sites were selected based on commitment from Rheumatology Fellowship Program Directors or previous experience with the Teaching Fellows in Lupus Project, after which LEAP was modeled. Sites identified a problem in lupus referrals and included ways to address the problem in the seminar. Examples of problems in referrals that were addressed in the seminar include 1) ANA titer not included in the referral; 2) patients referred with only a positive ANA and no relevant clinical symptoms included; 3) consults with rheumatology conducted prior to issuing a formal referral. Rates will be analyzed to assess if the seminar changed behavior.  Voluntary, anonymous pre/post assessments were used to evaluate changes in knowledge and behavior and collect qualitative data. A t-test was used to analyze independent group means.

Results:  Preliminary data from 427 assessments were analyzed on a 9-point scale. Total mean score increased 2.10 immediately post seminar and 2.88 points at 4-6 weeks post seminar (p<.01). Over 85% reported the 1) activity improved medical or practice knowledge and 2) they would make changes that will benefit patient care. Respondents are considering lupus more at 4-6 weeks post seminar.

Conclusion:  Rheumatology fellows can increase knowledge and promote behavior change in lupus assessment and referral among primary and emergency providers. LEAP may be an effective strategy to reduce health disparities in lupus. 

Table 1. Knowledge Change Pre/Post/4-6 Weeks Post Seminar
Assessment (Group Data)

N

Mean Score (SD)

Mean Score Change from Pre Assessment

P-Value

Pre Seminar

208

5.07 (2.38)

n/a

<.01

Post Seminar

199

7.17 (1.45)

2.10

<.01

4-6 Weeks Post Seminar

20

7.95 (1.90)

2.88

<.01

Table 2. Sustained Behavior Changes
Matched Assessments Pre to 4-6 Weeks Post

N=15

Question

Pre %

4-6 Weeks Post %

1) You consider lupus in your differential diagnosis during an exam?
Very Often

0 (0.0)

11 (73.3)

Somewhat Often

3 (20.0)

3 (20.0)

Not Very Often

1 (6.7)

1 (6.7)

Not At All

11 (73.3)

0 (0.0)

2) You refer patients to the rheumatologist for suspected lupus?
Extensively

1 (6.7)

12 (80.0)

Significantly

0 (0.0)

1 (6.7)

Occasionally

3 (20.0)

1 (6.7)

Seldom

0 (0.0)

1 (6.7)

Never

11 (73.3)

0 (0.0)

3) You refer patients to lupus educational material or other educational resources?
Always

0 (0.0)

11 (73.3)

Often

0 (0.0)

1 (6.7)

Occasionally

0 (0.0)

1 (6.7)

Rarely

3 (20.0)

2 (13.3)

Never

12 (80.0)

0 (0.0)


Disclosure: D. Gross, None; A. Caron, None; I. Blanco, None; A. Denio, None; S. Desai, None; A. Sammut, None; Z. Naqvi, None.

To cite this abstract in AMA style:

Gross D, Caron A, Blanco I, Denio A, Desai S, Sammut A, Naqvi Z. Lupus Education Advancement Project (LEAP): Rheumatology Fellows Serving As Educators Increased Knowledge and Efficiency in Lupus Recognition and Referral By Providers in Primary and Emergency Care [abstract]. Arthritis Rheumatol. 2016; 68 (suppl 10). https://acrabstracts.org/abstract/lupus-education-advancement-project-leap-rheumatology-fellows-serving-as-educators-increased-knowledge-and-efficiency-in-lupus-recognition-and-referral-by-providers-in-primary-and-emergency-care/. Accessed .
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to 2016 ACR/ARHP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/lupus-education-advancement-project-leap-rheumatology-fellows-serving-as-educators-increased-knowledge-and-efficiency-in-lupus-recognition-and-referral-by-providers-in-primary-and-emergency-care/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology